The New England Journal of Medicine,
An RSV prefusion F maternal vaccine was assessed for efficacy against RSV disease in infants. The trial was stopped early owing…
Maternal RSV Vaccine — Weighing Benefits and Risks
Overview of attention for article published in New England Journal of Medicine, March 2024
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (97th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (57th percentile)
Mentioned by
- news
- 9 news outlets
- blogs
- 1 blog
- policy
- 1 policy source
- 24 X users
- 1 Facebook page
Readers on
- mendeley
- 20 Mendeley